SCHEMBL17761565

SCHEMBL17761565

Cc1c(CCO)c(C2CC2)nn1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16006449 0.81 JAK2 (0.30) —
SCHEMBL17697521 0.79 NPSR1 (0.31) —
SCHEMBL16154694 0.78 — —
SCHEMBL14488052 0.74 ALDH1A1 (0.44) —
SCHEMBL14556095 0.66 JAK2 (0.45) —
SCHEMBL649338 0.57 — —
SCHEMBL1780791 0.57 SMN1; SMN2 (0.41) —
SCHEMBL28651140 0.57 PTGDR2 (0.31) —
SCHEMBL22411972 0.56 ALDH1A1 (0.31) —
SCHEMBL12806611 0.56 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016033243-A9 ANTIRETROVIRAL AGENTS GILEAD SCIENCES, INC. (US) 2016-05-19 — — WO disclosed
Send feedback